Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
申请人:Sanford Burnham Prebys Medical Discovery Institute
公开号:US11066420B2
公开(公告)日:2021-07-20
Protein tyrosine phosphatases (PTPs) are key regulators of metabolism and insulin signaling. As a negative regulator of insulin signaling, the low molecular weight protein tyrosine phosphatase (LMPTP) is a target for insulin resistance and related conditions. Described herein are compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and compositions, and methods of using these compounds and compositions.
蛋白酪氨酸磷酸酶(PTPs)是新陈代谢和胰岛素信号传导的关键调节因子。作为胰岛素信号转导的负调控因子,低分子量蛋白酪氨酸磷酸酶(LMPTP)是胰岛素抵抗及相关疾病的靶标。本文描述了能够调节低分子量蛋白酪氨酸磷酸酶(LMPTP)活性水平的化合物和组合物,以及使用这些化合物和组合物的方法。